Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.

150 Cyclists from EMD Millipore and EMD Serono Participated in 150 Mile Ride for MS

150 Cyclists from EMD Millipore and EMD Serono Participated in 150 Mile Ride for MS

EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany participated in and sponsored the Bike MS: Cape Cod Getaway ride to raise money for Multiple Sclerosis (MS).

Cyclists from Team "Reason to Ride" at the Cape Cod Getaway- a 150 Mike Bike Ride Which Raises Money ...

Cyclists from Team "Reason to Ride" at the Cape Cod Getaway- a 150 Mike Bike Ride Which Raises Money for the National MS Society

Who: EMD Millipore and EMD Serono, divisions of Merck KGaA of Germany

What: Participants and sponsors for the Cape Cod Getaway

When: Saturday, June 29 and Sunday, June 30

Where: The 150 mile route runs from Boston-Provincetown, Massachusetts

Why: 150 employees from EMD Millipore and EMD Serono participated in the Bike MS: Cape Cod Getaway event as part of team “Reason to Ride”. The two day, 150 mile ride started in Boston and ended in Provincetown, MA, attracting over 2,000 cyclists. This was the ninth year of participation for EMD Serono and Team “Reason to Ride.” As corporate sponsors of the event, employees from EMD Millipore and EMD Serono were encouraged to volunteer at rest stops along the route.

David Beattie, Senior R&D Director at EMD Millipore, has participated in MS Rides for 7 years, and has served as a captain of team “Reason to Ride” for 6 years. “People do this event for so many different reasons, which is how the team got its name,” says David. “I love the camaraderie of my team mates and other riders, the fantastic scenery, superb ride logistics and the amazing support we get from the community and the MS patients who come out to cheer us on. It’s my hope that our fundraising and few hours of hard work in the saddle can bring relief and encouragement to those who struggle every day.”

More than 400,000 people in North America live with MS. As a leading supplier of tools and technologies that support research for many chronic diseases including MS, EMD Millipore is proud to support the National Multiple Scleroses Society.

Fundraising totals can be viewed and additional donations made to team “Reason to Ride” here:

For more information and photos, please contact Cait Healey at [email protected] or 1-978-715-1663.

About EMD Millipore

EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany

About EMD Serono, INC:

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, endocrinology and in reproductive health. In addition, EMD Serono is growing its expertise and presence in the area of oncology, with more than 15 projects currently in development. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono’s US footprint continues to grow, with approximately 1,000 employees around the country and fully integrated commercial, clinical and research operations in the company’s home state of Massachusetts.


Rate this press release
0 stars


Add to favourites icon Add to favourites